Randall Curtis

1.1k total citations
43 papers, 778 citations indexed

About

Randall Curtis is a scholar working on Hematology, Genetics and Speech and Hearing. According to data from OpenAlex, Randall Curtis has authored 43 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hematology, 9 papers in Genetics and 4 papers in Speech and Hearing. Recurrent topics in Randall Curtis's work include Hemophilia Treatment and Research (37 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Adolescent and Pediatric Healthcare (4 papers). Randall Curtis is often cited by papers focused on Hemophilia Treatment and Research (37 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Adolescent and Pediatric Healthcare (4 papers). Randall Curtis collaborates with scholars based in United States, Canada and Ireland. Randall Curtis's co-authors include Michael B. Nichol, Megan M. Ullman, Brenda Riske, Denise Globe, Judith Baker, Thomas Rice, Marion A. Koerper, Jiat Ling Poon, Mark W. Skinner and Kathleen A. Johnson and has published in prestigious journals such as Blood, European Respiratory Journal and American Journal of Preventive Medicine.

In The Last Decade

Randall Curtis

41 papers receiving 745 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Randall Curtis United States 17 627 76 69 60 54 43 778
Alain M. Ngoma Japan 13 132 0.2× 51 0.7× 28 0.4× 10 0.2× 25 0.5× 25 387
Suman Pramanik India 8 91 0.1× 21 0.3× 174 2.5× 24 0.4× 24 0.4× 29 361
George Yeung Canada 8 309 0.5× 79 1.0× 116 1.7× 4 0.1× 20 0.4× 9 523
Karl Fernstrom United States 11 194 0.3× 38 0.5× 92 1.3× 10 0.2× 93 1.7× 20 419
Stanislas Okitotsho Wembonyama Democratic Republic of the Congo 11 204 0.3× 211 2.8× 28 0.4× 12 0.2× 18 0.3× 39 406
Grèce Saba France 9 67 0.1× 9 0.1× 27 0.4× 42 0.7× 48 0.9× 17 500
Joanna P. MacEwan United States 12 44 0.1× 23 0.3× 35 0.5× 118 2.0× 26 0.5× 53 391
Shannon Grant United States 10 39 0.1× 12 0.2× 25 0.4× 14 0.2× 22 0.4× 18 299
Behin Yektashenas United States 4 103 0.2× 69 0.9× 10 0.1× 25 0.4× 30 0.6× 9 260
Mohammed Zolaly Saudi Arabia 11 65 0.1× 78 1.0× 31 0.4× 2 0.0× 34 0.6× 33 367

Countries citing papers authored by Randall Curtis

Since Specialization
Citations

This map shows the geographic impact of Randall Curtis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randall Curtis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randall Curtis more than expected).

Fields of papers citing papers by Randall Curtis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randall Curtis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randall Curtis. The network helps show where Randall Curtis may publish in the future.

Co-authorship network of co-authors of Randall Curtis

This figure shows the co-authorship network connecting the top 25 collaborators of Randall Curtis. A scholar is included among the top collaborators of Randall Curtis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randall Curtis. Randall Curtis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lanzkron, Sophie, Joanne Wu, Randall Curtis, et al.. (2024). Costs and impact of disease in adults with sickle cell disease: a pilot study. Blood Advances. 8(14). 3629–3638. 4 indexed citations
2.
Curtis, Randall, Joanne Wu, Alfonso Iorio, et al.. (2024). Test–retest reliability of a mobile application of the patient reported outcomes burdens and experiences (PROBE) study. Haemophilia. 30(3). 702–708. 1 indexed citations
3.
Curtis, Randall, Jonathan Roberts, Judith Baker, et al.. (2023). Trends in prescribing practices for management of haemophilia: 1999–2021. Haemophilia. 29(3). 761–769. 2 indexed citations
4.
5.
Burke, Tom, Talaha M Ali, Nanxin Li, et al.. (2022). Association of factor expression levels with health-related quality of life and direct medical costs for people with haemophilia B. Journal of Medical Economics. 25(1). 386–392. 4 indexed citations
6.
Curtis, Randall, Marilyn J. Manco‐Johnson, Barbara A. Konkle, et al.. (2022). Comorbidities, Health-Related Quality of Life, Health-care Utilization in Older Persons with Hemophilia—Hematology Utilization Group Study Part VII (HUGS VII). Journal of Blood Medicine. Volume 13. 229–241. 8 indexed citations
7.
Roberts, Jonathan, Roshni Kulkarni, Peter A. Kouides, et al.. (2021). Depression and Anxiety in Persons with Von Willebrand Disease. Blood. 138(Supplement 1). 4052–4052. 4 indexed citations
8.
Witkop, Michelle, Cynthia Nichols, Angela Lambing, et al.. (2021). Understanding the Pain Management Landscape Within the US Bleeding Disorder Community: A Multi-Center Survey. Pain Medicine. 23(2). 269–279. 5 indexed citations
9.
Lanzkron, Sophie, Joanne Wu, Randall Curtis, et al.. (2021). PRO66 Health-Related Quality of Life in Persons with Sickle Cell Disease. Value in Health. 24. S209–S210. 1 indexed citations
10.
Chai‐Adisaksopha, Chatree, Declan Noone, Randall Curtis, et al.. (2020). Non‐severe haemophilia: Is it benign? – Insights from the PROBE study. Haemophilia. 27(S1). 17–24. 25 indexed citations
11.
Chai‐Adisaksopha, Chatree, Mark W. Skinner, Randall Curtis, et al.. (2018). Psychometric properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire. BMJ Open. 8(8). e021900–e021900. 19 indexed citations
12.
Nichol, Michael B., Yaping Xu, Judith Baker, et al.. (2017). Health-Related Quality of Life and Health Insurance Coverage Among Persons with Hemophilia A Inhibitors. Blood. 130. 4736–4736. 1 indexed citations
13.
Skinner, Mark W., Chatree Chai‐Adisaksopha, Randall Curtis, et al.. (2017). Burden of Comorbid Diseases in Patients with Hemophilia: The Cross-Sectional Analysis of the Patient Reported Outcomes, Burden and Experiences (PROBE) Study. Blood. 130. 3411–3411. 1 indexed citations
14.
Poon, Jiat Ling, Zhongmei Zhou, Jason N. Doctor, et al.. (2012). Quality of life in haemophilia A: Hemophilia Utilization Group Study Va (HUGS‐Va). Haemophilia. 18(5). 699–707. 58 indexed citations
15.
Zhou, Zheng‐Yi, Brenda Riske, Ann D. Forsberg, et al.. (2011). Self-Reported Barriers to Hemophilia Care in People with Factor VIII Deficiency. American Journal of Preventive Medicine. 41(6). S346–S353. 19 indexed citations
16.
Janssen, Daisy J.A., Martijn A. Spruit, Jos M. G. A. Schols, et al.. (2011). Stability of life-sustaining treatment preferences of patients with advanced chronic organ failure. European Respiratory Journal. 38(Suppl 55). 1889–1889. 1 indexed citations
17.
Zhou, Zhongmei, Joanne Wu, Judith Baker, et al.. (2011). Haemophilia Utilization Group Study – Part Va (HUGS Va): design, methods and baseline data. Haemophilia. 17(5). 729–736. 25 indexed citations
18.
19.
Globe, Denise, William E. Cunningham, Ronald Andersen, et al.. (2003). The Hemophilia Utilization Group Study (HUGS): determinants of costs of care in persons with haemophilia A. Haemophilia. 9(3). 325–331. 26 indexed citations
20.
Globe, Denise, William E. Cunningham, Ronald Andersen, et al.. (2002). Haemophilia Utilization Group Study: assessment of functional health status in haemophilia. Haemophilia. 8(2). 121–128. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alain M. Ngoma Breakdown of academic impact, for papers by Suman Pramanik Breakdown of academic impact, for papers by George Yeung Breakdown of academic impact, for papers by Karl Fernstrom Breakdown of academic impact, for papers by Stanislas Okitotsho Wembonyama Breakdown of academic impact, for papers by Grèce Saba Breakdown of academic impact, for papers by Joanna P. MacEwan Breakdown of academic impact, for papers by Shannon Grant Breakdown of academic impact, for papers by Behin Yektashenas Breakdown of academic impact, for papers by Mohammed Zolaly
Rankless by CCL
2026